- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour targeting with radiometals for diagnosis and therapy
Authors
Keywords
-
Journal
CHEMICAL COMMUNICATIONS
Volume 49, Issue 42, Pages 4720
Publisher
Royal Society of Chemistry (RSC)
Online
2013-04-02
DOI
10.1039/c3cc41554f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of 64Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability
- (2012) Maggie S. Cooper et al. BIOCONJUGATE CHEMISTRY
- Radiometals for Combined Imaging and Therapy
- (2012) Cathy S. Cutler et al. CHEMICAL REVIEWS
- Radiopharmaceutical development of radiolabelled peptides
- (2012) Melpomeni Fani et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Rationale for the use of radiolabelled peptides in diagnosis and therapy
- (2012) K. P. Koopmans et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiolabelled RGD peptides for imaging and therapy
- (2012) F. C. Gaertner et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- H2azapa: a Versatile Acyclic Multifunctional Chelator for 67Ga, 64Cu, 111In, and 177Lu
- (2012) Gwendolyn A. Bailey et al. INORGANIC CHEMISTRY
- Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography
- (2012) Mark D. Bartholomä INORGANICA CHIMICA ACTA
- Measurement of the rate of copper(II) exchange for 64Cu complexes of bifunctional chelators
- (2012) Vidhi Maheshwari et al. INORGANICA CHIMICA ACTA
- 177Lu–DO3A–HSA–ZEGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas
- (2012) Susan Hoppmann et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
- (2012) Scott M. Knowles et al. JOURNAL OF CLINICAL ONCOLOGY
- H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals
- (2012) Eric W. Price et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors
- (2012) Majiong Jiang et al. NUCLEAR MEDICINE AND BIOLOGY
- PET imaging with 89Zr: From radiochemistry to the clinic
- (2012) Melissa A. Deri et al. NUCLEAR MEDICINE AND BIOLOGY
- Gallium-68 Complex of a Macrobicyclic Cage Amine Chelator Tethered to Two Integrin-Targeting Peptides for Diagnostic Tumor Imaging
- (2011) Michelle T. Ma et al. BIOCONJUGATE CHEMISTRY
- TRAP, a Powerful and Versatile Framework for Gallium-68 Radiopharmaceuticals
- (2011) Johannes Notni et al. CHEMISTRY-A EUROPEAN JOURNAL
- Peptide Targeted Copper-64 Radiopharmaceuticals
- (2011) Michelle T. Ma et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Radiometallated peptides for molecular imaging and targeted therapy
- (2011) João D. G. Correia et al. DALTON TRANSACTIONS
- Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
- (2011) Kwon Yong et al. DALTON TRANSACTIONS
- Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals
- (2011) Sibaprasad Bhattacharyya et al. DALTON TRANSACTIONS
- A practical guide to the construction of radiometallated bioconjugates for positron emission tomography
- (2011) Brian M. Zeglis et al. DALTON TRANSACTIONS
- The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticals
- (2011) Paul S. Donnelly DALTON TRANSACTIONS
- 99mTc-centered one-pot synthesis for preparation of 99mTc radiotracers
- (2011) Shuang Liu et al. DALTON TRANSACTIONS
- Macrobicyclic Cage Amine Ligands for Copper Radiopharmaceuticals: A Single Bivalent Cage Amine Containing Two Lys3-bombesin Targeting Peptides
- (2011) Michelle T. Ma et al. INORGANIC CHEMISTRY
- Preparation and preliminary biological evaluation of 177Lu-labeled GluDTPA-cyclo(RGDfK) for integrin ανβ3 receptor-positive tumor targeting
- (2011) Jin-Hwan Kim et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- The Development of Copper Radiopharmaceuticals for Imaging and Therapy
- (2011) Monica Shokeen et al. Medicinal Chemistry
- Two90Y-Labeled Multimeric RGD Peptides RGD4 and 3PRGD2 for Integrin Targeted Radionuclide Therapy
- (2011) Zhaofei Liu et al. MOLECULAR PHARMACEUTICS
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model
- (2011) Anna M.E. Gustafsson et al. NUCLEAR MEDICINE AND BIOLOGY
- Molecular imaging with SPECT as a tool for drug development
- (2010) Célia M. Gomes et al. ADVANCED DRUG DELIVERY REVIEWS
- Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers
- (2010) Jiyun Shi et al. AMINO ACIDS
- Evaluation of Bifunctional Chelates for the Development of Gallium-Based Radiopharmaceuticals
- (2010) Cara L. Ferreira et al. BIOCONJUGATE CHEMISTRY
- Stabilized111In-Labeled sCCK8 Analogues for Targeting CCK2-Receptor Positive Tumors: Synthesis and Evaluation
- (2010) Susan Roosenburg et al. BIOCONJUGATE CHEMISTRY
- Targeted Therapies in Cancer
- (2010) Sabino Ciavarella et al. BIODRUGS
- Clickable bifunctional radiometal chelates for peptide labeling
- (2010) Artem Y. Lebedev et al. CHEMICAL COMMUNICATIONS
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
- (2010) Thaddeus J. Wadas et al. CHEMICAL REVIEWS
- A Triazacyclononane-Based Bifunctional Phosphinate Ligand for the Preparation of Multimeric68Ga Tracers for Positron Emission Tomography
- (2010) Johannes Notni et al. CHEMISTRY-A EUROPEAN JOURNAL
- Sequential Cytarabine and -Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
- (2010) T. L. Rosenblat et al. CLINICAL CANCER RESEARCH
- Click-Chemistry Reactions in Radiopharmaceutical Chemistry: Fast & Easy Introduction of Radiolabels into Biomolecules for In Vivo Imaging
- (2010) C. Wangler et al. CURRENT MEDICINAL CHEMISTRY
- 99mTc-Radiolabelled Peptides for Tumour Imaging: Present and Future
- (2010) C. Bolzati et al. CURRENT MEDICINAL CHEMISTRY
- Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
- (2010) Rosalba Mansi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET imaging of tumor angiogenesis in mice with VEGF-A-targeted 86Y-CHX-A″-DTPA-bevacizumab
- (2010) Tapan K. Nayak et al. INTERNATIONAL JOURNAL OF CANCER
- Methotrexate, Paclitaxel, and Doxorubicin Radiosensitize HER2-Amplified Human Breast Cancer Cells to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab
- (2010) D. L. Costantini et al. JOURNAL OF NUCLEAR MEDICINE
- Acyclic Chelate with Ideal Properties for68Ga PET Imaging Agent Elaboration
- (2010) Eszter Boros et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM
- (2010) Jason L.J. Dearling et al. NUCLEAR MEDICINE AND BIOLOGY
- Antibody Vectors for Imaging
- (2010) Tove Olafsen et al. SEMINARS IN NUCLEAR MEDICINE
- (S)-5-(p-Nitrobenzyl)-PCTA, a Promising Bifunctional Ligand with Advantageous Metal Ion Complexation Kinetics
- (2009) Gyula Tircsó et al. BIOCONJUGATE CHEMISTRY
- Nonnatural Amino Acids for Site-Specific Protein Conjugation
- (2009) Albert J. de Graaf et al. BIOCONJUGATE CHEMISTRY
- Targeting the v 3 Integrin for Small-Animal PET/CT of Osteolytic Bone Metastases
- (2009) T. J. Wadas et al. JOURNAL OF NUCLEAR MEDICINE
- Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
- (2009) E. C.F. Dijkers et al. JOURNAL OF NUCLEAR MEDICINE
- The Advantages of Nanoparticles for PET
- (2009) M. J. Welch et al. JOURNAL OF NUCLEAR MEDICINE
- Some physical aspects of positron annihilation tomography: A critical review
- (2009) B. N. Ganguly et al. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
- Melanoma imaging using 111In-, 86Y- and 68Ga-labeled CHX-A″-Re(Arg11)CCMSH
- (2009) Lihui Wei et al. NUCLEAR MEDICINE AND BIOLOGY
- Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer
- (2008) Misara Hamoudeh et al. ADVANCED DRUG DELIVERY REVIEWS
- Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
- (2008) Shuang Liu ADVANCED DRUG DELIVERY REVIEWS
- Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
- (2008) Matthias Miederer et al. ADVANCED DRUG DELIVERY REVIEWS
- Synthesis of11C,18F,15O, and13N Radiolabels for Positron Emission Tomography
- (2008) Philip W. Miller et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeted Tumor Diagnosis and Therapy with Peptide Hormones as Radiopharmaceuticals
- (2008) Annette Beck-Sickinger et al. Anti-Cancer Agents in Medicinal Chemistry
- Synthesis of a Cross-Bridged Cyclam Derivative for Peptide Conjugation and64Cu Radiolabeling
- (2008) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- 99m-Technetium carbohydrate conjugates as potential agents in molecular imaging
- (2008) Meryn L. Bowen et al. CHEMICAL COMMUNICATIONS
- “Click‐to‐Chelate”: Design and Incorporation of Triazole‐Containing Metal‐Chelating Systems into Biomolecules of Diagnostic and Therapeutic Interest
- (2008) Harriet Struthers et al. CHEMISTRY-A EUROPEAN JOURNAL
- 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals
- (2008) Melpomeni Fani et al. Contrast Media & Molecular Imaging
- Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals
- (2008) Cara L. Ferreira et al. NUCLEAR MEDICINE AND BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More